Literature DB >> 25562836

Heparin inhibits the inflammatory response induced by LPS and HMGB1 by blocking the binding of HMGB1 to the surface of macrophages.

Li Li1, Yan Ling1, Min Huang1, Tao Yin1, Shan-Miao Gou1, Nai-Yang Zhan1, Jiong-Xin Xiong1, He-Shui Wu1, Zhi-Yong Yang2, Chun-You Wang3.   

Abstract

High mobility group box 1 protein (HMGB1), a nuclear non-histone DNA-binding protein, is secreted extracellularly during inflammation and is a late mediator of inflammatory responses. The pro-inflammatory activity of recombinant HMGB1 proteins is dependent upon the formation of complexes with other mediators, such as lipopolysaccharide (LPS). This study investigated the influence of heparin on LPS+HMGB1-mediated inflammatory responses in cultured macrophages and a murine sepsis model. HMGB1 promoted the phosphorylation of p38 and ERK1/2. HMGB1 enhanced the induction of the pro-inflammatory cytokine, TNF-α, by LPS in macrophages. Heparin blocked the binding of HMGB1 to the surface of macrophages, and suppressed the phosphorylation of p38 and ERK1/2, but not JNK; TNF-α secretion was also decreased. However, heparin alone did not affect LPS-induced production of TNF-α. Heparin reduced lethality in mice exposed to LPS+HMGB1. To conclude, heparin inhibited LPS-induced HMGB1-amplified inflammatory responses by blocking HMGB1 binding to macrophage surfaces. Heparin could be used therapeutically as an effective inhibitor of HMGB1-associated inflammation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Heparin; High mobility group box 1 protein; Lipopolysaccharide; Mitogen-activated protein kinase; Tumour necrosis factor-α

Mesh:

Substances:

Year:  2015        PMID: 25562836     DOI: 10.1016/j.cyto.2014.12.010

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  21 in total

Review 1.  The role of neutrophils in thrombosis.

Authors:  Sargam Kapoor; Aman Opneja; Lalitha Nayak
Journal:  Thromb Res       Date:  2018-08-09       Impact factor: 3.944

2.  2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity.

Authors:  Shuo Zheng; Apparao B Kummarapurugu; Daniel K Afosah; Nehru Viji Sankaranarayanan; Rio S Boothello; Umesh R Desai; Thomas Kennedy; Judith A Voynow
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

Review 3.  Heparan Sulfate in the Developing, Healthy, and Injured Lung.

Authors:  Sarah M Haeger; Yimu Yang; Eric P Schmidt
Journal:  Am J Respir Cell Mol Biol       Date:  2016-07       Impact factor: 6.914

4.  Unfractionated heparin attenuates intestinal injury in mouse model of sepsis by inhibiting heparanase.

Authors:  Song Chen; Xiaojuan Zhang; Yini Sun; Ziwei Hu; Siyu Lu; Xiaochun Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

5.  Sepsis take-out: Inhibiting bacterial deliveries.

Authors:  Shelbi Christgen; Thirumala-Devi Kanneganti
Journal:  Immunity       Date:  2021-03-09       Impact factor: 31.745

6.  Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice.

Authors:  Konstantin Stark; Vanessa Philippi; Sven Stockhausen; Johanna Busse; Antonella Antonelli; Meike Miller; Irene Schubert; Parandis Hoseinpour; Sue Chandraratne; Marie-Luise von Brühl; Florian Gaertner; Michael Lorenz; Alessandra Agresti; Raffaele Coletti; Daniel J Antoine; Ralf Heermann; Kirsten Jung; Sven Reese; Iina Laitinen; Markus Schwaiger; Axel Walch; Markus Sperandio; Peter P Nawroth; Christoph Reinhardt; Sven Jäckel; Marco E Bianchi; Steffen Massberg
Journal:  Blood       Date:  2016-08-29       Impact factor: 22.113

7.  Heparin and LPS-induced COX-2 expression in airway cells: a link between its anti-inflammatory effects and GAG sulfation.

Authors:  Na Young Yi; Donna R Newman; Huiying Zhang; Helena Morales Johansson; Philip L Sannes
Journal:  Exp Lung Res       Date:  2015       Impact factor: 2.459

8.  Annexin A5 increases survival in murine sepsis model by inhibiting HMGB1-mediated pro-inflammation and coagulation.

Authors:  Jung Hwa Park; Jong-Hwa Jang; Eun Jung Choi; Young Seob Kim; Eun Ji Lee; In Duk Jung; Hee Dong Han; T-C Wu; Chien-Fu Hung; Tae Heung Kang; Yeong-Min Park
Journal:  Mol Med       Date:  2016-07-06       Impact factor: 6.354

9.  Does enoxaparin interfere with HMGB1 signaling after TBI? A potential mechanism for reduced cerebral edema and neurologic recovery.

Authors:  Shengjie Li; Rachel Eisenstadt; Kenichiro Kumasaka; Victoria E Johnson; Joshua Marks; Katsuhiro Nagata; Kevin D Browne; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2016-03       Impact factor: 3.313

10.  Venous thromboembolism prevention with low molecular weight heparin may reduce hemorrhagic transformation in acute ischemic stroke.

Authors:  Antonio Muscari; Elena Bartoli; Luca Faccioli; Elena Franchi; Marco Pastore Trossello; Giovanni M Puddu; Luca Spinardi; Marco Zoli
Journal:  Neurol Sci       Date:  2020-03-24       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.